ADAP
Goldman Sachs’s Adaptimmune Therapeutics ADAP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-16,149
| Closed | -$3.18K | – | 5116 |
|
|
2025
Q1 | $3.18K | Sell |
16,149
-11
| -0.1% | -$2 | ﹤0.01% | 5034 |
|
|
2024
Q4 | $8.71K | Sell |
16,160
-68,250
| -81% | -$36.8K | ﹤0.01% | 4945 |
|
|
2024
Q3 | $80.2K | Buy |
84,410
+68,291
| +424% | +$64.9K | ﹤0.01% | 4626 |
|
|
2024
Q2 | $15.7K | Sell |
16,119
-91,443
| -85% | -$89.1K | ﹤0.01% | 4620 |
|
|
2024
Q1 | $170K | Buy |
107,562
+91,583
| +573% | +$145K | ﹤0.01% | 4367 |
|
|
2023
Q4 | $12.7K | Sell |
15,979
-41,632
| -72% | -$33K | ﹤0.01% | 4637 |
|
|
2023
Q3 | $44.9K | Buy |
57,611
+9,534
| +20% | +$7.44K | ﹤0.01% | 4492 |
|
|
2023
Q2 | $44.5K | Buy |
48,077
+17,332
| +56% | +$16K | ﹤0.01% | 4684 |
|
|
2023
Q1 | $33.5K | Sell |
30,745
-110,154
| -78% | -$120K | ﹤0.01% | 4820 |
|
|
2022
Q4 | $206K | Sell |
140,899
-304,294
| -68% | -$444K | ﹤0.01% | 4489 |
|
|
2022
Q3 | $479K | Buy |
445,193
+83,092
| +23% | +$89.4K | ﹤0.01% | 4281 |
|
|
2022
Q2 | $616K | Buy |
362,101
+2,182
| +0.6% | +$3.71K | ﹤0.01% | 4245 |
|
|
2022
Q1 | $741K | Buy |
359,919
+51,408
| +17% | +$106K | ﹤0.01% | 4326 |
|
|
2021
Q4 | $1.16M | Sell |
308,511
-21,867
| -7% | -$82K | ﹤0.01% | 3913 |
|
|
2021
Q3 | $1.71M | Sell |
330,378
-50,783
| -13% | -$263K | ﹤0.01% | 3604 |
|
|
2021
Q2 | $1.62M | Buy |
381,161
+334,023
| +709% | +$1.42M | ﹤0.01% | 3668 |
|
|
2021
Q1 | $250K | Sell |
47,138
-3,910
| -8% | -$20.7K | ﹤0.01% | 4729 |
|
|
2020
Q4 | $275K | Sell |
51,048
-535,395
| -91% | -$2.88M | ﹤0.01% | 4121 |
|
|
2020
Q3 | $4.68M | Buy |
586,443
+147,773
| +34% | +$1.18M | ﹤0.01% | 2428 |
|
|
2020
Q2 | $4.39M | Buy |
+438,670
| New | +$4.39M | ﹤0.01% | 2405 |
|
|
2019
Q4 | – | Sell |
-35,348
| Closed | -$53K | – | 4270 |
|
|
2019
Q3 | $53K | Buy |
35,348
+6,603
| +23% | +$9.9K | ﹤0.01% | 4115 |
|
|
2019
Q2 | $116K | Sell |
28,745
-27,837
| -49% | -$112K | ﹤0.01% | 3971 |
|
|
2019
Q1 | $243K | Buy |
56,582
+21,201
| +60% | +$91.1K | ﹤0.01% | 3816 |
|
|
2018
Q4 | $203K | Buy |
35,381
+9,088
| +35% | +$52.1K | ﹤0.01% | 3735 |
|
|
2018
Q3 | $357K | Sell |
26,293
-15,051
| -36% | -$204K | ﹤0.01% | 3588 |
|
|
2018
Q2 | $491K | Sell |
41,344
-14,313
| -26% | -$170K | ﹤0.01% | 3527 |
|
|
2018
Q1 | $625K | Sell |
55,657
-31,735
| -36% | -$356K | ﹤0.01% | 3392 |
|
|
2017
Q4 | $584K | Buy |
87,392
+37,792
| +76% | +$253K | ﹤0.01% | 3381 |
|
|
2017
Q3 | $406K | Buy |
49,600
+39,349
| +384% | +$322K | ﹤0.01% | 3601 |
|
|
2017
Q2 | $46K | Buy |
+10,251
| New | +$46K | ﹤0.01% | 4254 |
|
|
2016
Q3 | – | Sell |
-19,574
| Closed | -$160K | – | 4526 |
|
|
2016
Q2 | $160K | Buy |
+19,574
| New | +$160K | ﹤0.01% | 3951 |
|